PETQ - ペットIQ （PetIQ Inc.）

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA ) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich''s Ataxia. OncoSec Medical Incorporated (NASDAQ: ONCS ) jumped 122.7% to $2.4050 after the company requested withdrawal of registration statement. The company said it has opted not to pursue offering thereby at this time. HPX Corp. (NYSE: HPX ) gained 51.3% to $14.96. Lucira Health, Inc. (NASDAQ: LHDX ) gained 31% to $1.2250. Lucira Health recently announced FDA authorization for its at-home combination COVID-19 & flu test. Nerdy, Inc. (NYSE: NRDY ) surged 29.6% to $3.2550 following better-than-expected Q4 results. Helbiz Inc (NASDAQ: HLBZ ) rose 28.6% to $0.1786 after gaining over 21% on Tuesday. B&G Foods, Inc. (NYSE: BGS ) jumped 27.6% to $16.17 after the company reported better-than-expected Q4 results. Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB ) gained 25.5% to $10.64 after the company reported Q4 results. Sarepta Therapeutics Inc (NASDAQ: SRPT ) rose 23.4% to $150.73 after the company reported better-than-expected Q4 results.

Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $ 48.0 Million Completes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook

PetIQ (NASDAQ: PETQ ) is set to give its latest quarterly earnings report on Tuesday, 2023-02-28. Here''s what investors need to know before the announcement. Analysts estimate that PetIQ will report an earnings per share (EPS) of $-0.09. PetIQ bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide … Full story available on Benzinga.com

EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022, on Tuesday, February 28, 2023, after the market close.

PetIQ''s manufactured products saw exceptional performance in Q3. Read more to see why we rate PETQ stock a buy.

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA ) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich''s Ataxia. OncoSec Medical Incorporated (NASDAQ: ONCS ) jumped 122.7% to $2.4050 after the company requested withdrawal of registration statement. The company said it has opted not to pursue offering thereby at this time. HPX Corp. (NYSE: HPX ) gained 51.3% to $14.96. Lucira Health, Inc. (NASDAQ: LHDX ) gained 31% to $1.2250. Lucira Health recently announced FDA authorization for its at-home combination COVID-19 & flu test. Nerdy, Inc. (NYSE: NRDY ) surged 29.6% to $3.2550 following better-than-expected Q4 results. Helbiz Inc (NASDAQ: HLBZ ) rose 28.6% to $0.1786 after gaining over 21% on Tuesday. B&G Foods, Inc. (NYSE: BGS ) jumped 27.6% to $16.17 after the company reported better-than-expected Q4 results. Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB ) gained 25.5% to $10.64 after the company reported Q4 results. Sarepta Therapeutics Inc (NASDAQ: SRPT ) rose 23.4% to $150.73 after the company reported better-than-expected Q4 results.

Full Year 2022 Net Sales and Adjusted EBITDA In-Line with Company Guidance Updates Adjusted EBITDA Methodology Reports Record Annual Cash from Operations of $ 48.0 Million Completes Complementary, Margin Accretive Acquisition of Rocco & Roxie Provides First Quarter 2023 and Full Year 2023 Outlook

PetIQ (NASDAQ: PETQ ) is set to give its latest quarterly earnings report on Tuesday, 2023-02-28. Here''s what investors need to know before the announcement. Analysts estimate that PetIQ will report an earnings per share (EPS) of $-0.09. PetIQ bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide … Full story available on Benzinga.com

EAGLE, Idaho, Jan. 31, 2023 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022, on Tuesday, February 28, 2023, after the market close.

PetIQ''s manufactured products saw exceptional performance in Q3. Read more to see why we rate PETQ stock a buy.

PetIQ''s manufactured products saw exceptional performance in Q3. Read more to see why we rate PETQ stock a buy.

In recent trading session, PetIQ Inc. (NASDAQ:PETQ) saw 0.74 million shares changing hands at last check today with its beta currently measuring 1.67. Company’s recent per share price level of $11.27 trading at $0.23 or 2.13% at last check today assigns it a market valuation of $315.96M. That most recent trading price of PETQ’s stock … PetIQ Inc. (NASDAQ:PETQ) Is Currently -125.38% Below Its 52-Week High, But Downside Potential Could Surprise You. Read More »

PetIQ Inc. (NASDAQ:PETQ) concluded the trading at $11.04 on Wednesday, November 23 with a fall of -1.60% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $11.22 and 5Y monthly beta was reading 1.60 with its price kept floating in the range … The Behavior Of PetIQ Inc. (PETQ) Stock Is Not As Predictable As You Think Read More »

Gainers Fast Radius, Inc. (NASDAQ: FSRD ) shares jumped 156.2% to close at $0.2608 on Thursday after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company''s voluntary Chapter 11 petitions filed on November 7. SHF Holdings, Inc. (NASDAQ: SHFS ) jumped 86.7% to close at $3.79 on Thursday. EpicQuest Education Group International Limited (NASDAQ: EEIQ ) rose 72.1% to close at $1.79. Magnite, Inc. (NASDAQ: MGNI ) shares surged 65.6% to close at $9.57 after the company reported better-than-expected Q3 results. TG Therapeutics, Inc. (NASDAQ: TGTX ) jumped 63.4% to close at $8.43 following narrower-than-expected Q3 loss. Digital Turbine, Inc. (NASDAQ: APPS ) shares climbed 60.9% to close at $17.33 after reporting upbeat Q2 earnings. Cosmos Holdings Inc. (NASDAQ: COSM ) gained 57.5% to settle at $0.1150. Repay Holdings Corporation (NASDAQ: RPAY ) climbed 50.7% to close at $6.60 after the company reported upbeat Q3 results. BioLife Solutions, Inc. (NASDAQ: BLFS ) surged 42.8% to close at $24.70 after reporting Q3 results.